. "Appendix B: Agenda." The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Opportunities for Integrated Intervention Strategies: Workshop Summary. Washington, DC: The National Academies Press, 2011.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Opportunities for Integrated Intervention Strategies
B
Agenda
The Causes and Impacts of Neglected Tropical andZoonotic Diseases: Implications for Global Health andOpportunities for Novel Intervention Strategies
September 21–22, 2010
Keck Building, Room 100
500 Fifth Street, NW
Washington, DC
DAY 1: Tuesday, September 21, 2010
8:00–8:30:
Registration and Continental Breakfast
8:30–8:45:
Welcoming Remarks
David Relman, M.D., Chair, and James Hughes, M.D., Vice-Chair, Forum on Microbial Threats
8:45–10:15:
Keynote Remarks
David Relman, Moderator
8:45–9:30
Opportunities for medical diplomacy: The Global Health Initiative
Ezekiel Emanuel, M.D., Ph.D., White House Office of Management and Budget
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole. Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 523
The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Opportunities for Integrated Intervention Strategies
B
Agenda
The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Implications for Global Health and Opportunities for Novel Intervention Strategies
September 21–22, 2010
Keck Building, Room 100
500 Fifth Street, NW
Washington, DC
DAY 1: Tuesday, September 21, 2010
8:00–8:30:
Registration and Continental Breakfast
8:30–8:45:
Welcoming Remarks
David Relman, M.D., Chair, and James Hughes, M.D., Vice-Chair, Forum on Microbial Threats
8:45–10:15:
Keynote Remarks
David Relman, Moderator
8:45–9:30
Opportunities for medical diplomacy: The Global Health Initiative
Ezekiel Emanuel, M.D., Ph.D., White House Office of Management and Budget
OCR for page 524
The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Opportunities for Integrated Intervention Strategies
9:30–10:15
NTDs slated for elimination and eradication
Donald Hopkins, M.D., M.P.H., The Carter Center
10:15–10:45:
Discussion
10:45–11:00:
Break
Session One:
An Overview of the NTDs
James Hughes, Moderator
11:00–11:30:
Neglected infections of poverty in the United States
Peter Hotez, M.D., Ph.D., The George Washington University
11:30–12:00:
NTDs in the setting of conflict
Chris Beyrer, M.D., M.P.H., Johns Hopkins University
12:00–12:30:
Parasite prevalence and the worldwide distribution of cognitive ability
Christopher Eppig, University of New Mexico
12:30–1:00:
Discussion of Session One
1:00–1:45:
Lunch
Session Two:
Global Burden of Disease/Opportunities for Control
Mary Wilson, Moderator
1:45–2:15:
The social and environmental context of infectious diseases occurrence in Brazil: Interventions, policies, and research needs
Mauricio Barreto, M.D., M.P.H., Ph.D., Federal University of Bahia in Salvador, Brazil
2:15–2:45:
Neglected tropical and zoonotic diseases and their impact on women and children’s health
Marian McDonald, Dr.P.H., M.P.H., M.A., Centers for Disease Control and Prevention
OCR for page 525
The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Opportunities for Integrated Intervention Strategies
2:45–3:15:
Addressing the social determinants of the NTDs in devising an integrated control strategy
Jerry Spiegel, Ph.D., M.A., M.Sc., University of British Columbia
3:15–3:30:
Break
3:30–4:00:
Reemergence of dengue in the United States?
Harold Margolis, M.D., Centers for Disease Control and Prevention
4:00–4:30:
Chagas disease in the Americas: Health impacts and opportunities for control
Rick L. Tarleton, Ph.D., The University of Georgia and The Chagas Disease Foundation
4:30–5:00:
Schistosomiasis
Charles King, M.D., M.S., Case Western Reserve University
5:00–5:30:
Progress in the control and elimination of human African trypanosomiasis
Jean Jannin, M.D., World Health Organization
5:30–6:00:
Integrated control of tropical diseases: Progress in the control and elimination of lymphatic filariasis
Eric Ottesen, M.D., The Task Force for Global Health
6:00–6:30:
Discussion of Session Two; Open Discussion of Day One
6:30:
Adjourn
DAY 2: September 22, 2010
8:00–8:15:
Continental Breakfast
8:15–8:30:
Summary of Day One: James M. Hughes, M.D., Vice-Chair, Forum on Microbial Threats
8:30–9:00:
Keynote Remarks: Christy Hanson, Ph.D., U.S. Agency for International Development
James M. Hughes, Moderator
OCR for page 526
The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Opportunities for Integrated Intervention Strategies
9:00–9:15:
Discussion
Session Three:
Governmental and Nongovernmental Approaches to Integrated Disease Control
Kevin Russell, Moderator
9:15–9:45:
Neglected zoonotic diseases
Lonnie King, D.V.M., The Ohio State University
9:45–10:15:
Regional approaches to NTD control in the Americas
Steven Ault, Pan American Health Organization
10:15–10:45:
The neglected tropical diseases in Africa and next steps for global control and elimination
Lorenzo Savioli, M.D., M.Sc., DTM&H, World Health Organization
10:45–11:00:
Break
11:00–11:30:
The U.K. commitment to NTD control
Alan Fenwick, Imperial College of London
11:30–12:00:
The Gates Foundation commitment to NTD control
Julie Jacobson, M.D., DTM&H, The Bill & Melinda Gates Foundation
12:00–12:30:
Discussion
12:30–1:15:
Luncheon Remarks: Jesse Goodman, M.D., M.P.H., Chief Scientist, Food and Drug Administration
“Can we collaborate to develop new paradigms and approaches for public health product development and evaluation?”
Session Four:
Unmet Needs: Development of Diagnostics, Drugs, and Vaccines to Control or Treat the Most Common NTDs
David Relman, Moderator
1:15–1:45:
Public–private partnerships addressing diseases of the developing world: Lessons learned; current challenges; future opportunities
Mark Feinberg, M.D., Ph.D., Merck & Co.
OCR for page 527
The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Opportunities for Integrated Intervention Strategies
1:45–2:15:
New drugs in clinical development
Shing Chang, Ph.D., DNDi
2:15–2:45:
Need for improved diagnostics
Patrick Lammie, Ph.D., M.S., Centers for Disease Control and Prevention
2:45–3:00:
Break
3:00–3:30:
R&D Investments
Mary Moran, M.D., Policy Cures, Sydney, Australia, London, UK
3:30–4:00:
Antihelminthic vaccines
Peter Hotez, M.D., Ph.D., The George Washington University
4:00–4:45:
Open Panel Discussion
4:45–5:00:
Closing Remarks
James Hughes and David Relman
5:00:
Meeting Adjourned
OCR for page 528
The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Opportunities for Integrated Intervention Strategies
This page intentionally left blank.
